Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03185546 · ClinicalTrials.gov registry record · NA
Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 156
- Enrollment target
NCT03185546 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 156 participants.
The verdict
NCT03185546, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 156 participants
- Enrollment target
Study Summary
Project 2 will evaluate the impact of very low nicotine content cigarettes, e-cigarette nicotine content, and e-cigarette flavoring on cigarettes smoked per day, nicotine exposure, puff topography, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use, cardiovascular function, and perceived risk. Project 2 will also evaluate differences between conditions in compliance with product use and the ability to abstain from cigarette smoking when provided a financial incentive for abstinence from combusted tobacco. This is not a treatment program for smoking.
Interventions
- OTHER NNC Spectrum Cigarette
- OTHER VLNC Spectrum Cigarette
- OTHER Moderate nicotine level e-liquid
- OTHER Low nicotine level e-liquid
- OTHER Tobacco Flavors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2018-08-06 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03185546
The ClinicalTrials.gov registry entry for NCT03185546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which NNC Spectrum Cigarette is the first listed.
NCT03185546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03185546 about?
NCT03185546 is a clinical study titled "Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors". Project 2 will evaluate the impact of very low nicotine content cigarettes, e-cigarette nicotine content, and e-cigarette flavoring on cigarettes smoked per day, nicotine exposure, puff topography, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tob...
What is the current status of trial NCT03185546?
This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2018-08-06. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03185546?
The interventions under investigation include: NNC Spectrum Cigarette (OTHER), VLNC Spectrum Cigarette (OTHER), Moderate nicotine level e-liquid (OTHER), Low nicotine level e-liquid (OTHER), Tobacco Flavors (OTHER).
Who is sponsoring clinical trial NCT03185546?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.